Bloomberg Law
Health Law & Business News

Alternative to Obamacare Hit With Crackdown by Biden Agencies

The Biden administration plans to issue a final rule on Thursday to curb the sale and availability of “short-term limited-duration insurance” plans, which critics say provide low-cost, but low-quality, coverage that skirts consumer protections in the Affordable Care Act.

Novo’s $1,000 Diabetes Drug Can Be Made for Under $5 a Month

Ozempic could be profitably produced for less than $5 a month even as maker Novo Nordisk A/S charges almost $1,000 in the US, according to a study that revives questions about prices for top-selling treatments for diabetes and obesity.

Landmark Washington Health Data Privacy Law Creates Suit Risks

Businesses dealing with health-related data in Washington state will be subject to new litigation and enforcement risks next week, as a far-reaching health privacy law takes effect.

Ninth Circuit Slams Idaho AG for Not Defending Abortion Letter

A panel of federal appeals court judges slammed the Idaho attorney general’s lawyer for failing to argue that a lawsuit brought by abortion providers is wrong on the merits.

AstraZeneca Sues to Block Arkansas Contract Pharmacy Law

Pharmaceutical giant AstraZeneca is seeking to block an Arkansas law that prohibits manufacturers from placing restrictions on pharmacies that take part in a federal drug discount program.

PRACTITIONER INSIGHTS

View More Insights

Latest Stories

Alternative to Obamacare Hit With Crackdown by Biden Agencies

The Biden administration plans to issue a final rule on Thursday to curb the sale and availability of “short-term limited-duration insurance” plans, which critics say provide low-cost, but low-quality, coverage that skirts consumer protections in the Affordable Care Act.

Troubled NJ Hospital Chain Taps Insight to Stabilize Finances

A Michigan company that rescued a bankrupt Chicago hospital has stepped in to run operations at <-bsp-bb-link state="{"bbHref":"bbg://securities/1822065D%20US%20Equity","_id":"0000018e-8366-dd73-a18e-c76785a90000","_type":"0000016b-944a-dc2b-ab6b-d57ba1cc0000"}">CarePoint Health, the long-troubled system across the river from Manhattan.

Bayer-Backed Drug Maker Boundless Bio Raises $100 Million in IPO

<-rte-company state="{"_id":"0000018e-8237-dd73-a18e-c7379ceb0000","_type":"00000160-4b23-d8bd-adfd-4b3348fd0000"}">Boundless Bio Inc., a cancer therapeutics maker that counts <-rte-company state="{"_id":"0000018e-8237-dd73-a18e-c7379ceb0001","_type":"00000160-4b23-d8bd-adfd-4b3348fd0000"}">Bayer AG among its largest investors, raised $100 million in a US initial public offering after pricing shares at the midpoint of a marketed range.

Valsartan Adulteration Lawsuit Sees Most Claims Head to Trial

Labels identifying drugs as valsartan constituted express warranties about the medications’ safety, but whether manufacturers breached the warranty depends on disputed facts, a federal judge said ahead of a bellwether trial in litigation alleging generic blood pressure medications were contaminated by a carcinogenic substance.

Beyond Abortion: The Fight Over Fetal Personhood Is Here

When do legal rights begin, at birth or before that? This video looks at the fetal personhood movement, and what it could mean for the future of abortion. We explore its history and the constitutional argument underpinning it.

From Across Bloomberg Law

Business & Practice Environment & Energy Report Environmental, Social & Governance (ESG) The United States Law Week
  • Business & Practice
  • Environment & Energy Report
  • Environmental, Social & Governance (ESG)
  • The United States Law Week

Home Depot to Buy Roof-Supply Firm SRS for About $18.25 Billion

Home Depot Inc. said it would buy roof-supply firm <-bsp-bb-link state="{"bbHref":"bbg://securities/0742294D%20US%20Equity","_id":"0000018e-84be-dd73-a18e-c7bf053f0001","_type":"0000016b-944a-dc2b-ab6b-d57ba1cc0000"}">SRS Distribution Inc. for about $18.25 billion in a bid to bolster the company’s professional services business.

Covid Vaccine & Personal Data: Does HIPAA Still Matter?